Caudill Seed & Warehouse Inc FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on April 14, 2017
Executive Summary
The FDA issued a warning letter to Caudill Seed & Warehouse Inc on April 14, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Cincinnati District Office.
Detailed Analysis
False Claims and Regulatory Violations
“ [N]ovel candidates for use in cancer chemoprevention,
“Sulforaphane (SFN) …First identified in 1992 as a potential chemopreventive agent,
“[T]he effects of SFN on cell viability were described in HT-29 human colon cancer cells, where 100 μM SFN for 24 or 48 h resulted in a decrease in cell viability … Similar responses have been observed in human prostate cancer cells after treatment with SFN,”
Potential Health Risks
“Protecting the skin from harmful UV radiation.”
Regulatory Context
“Studies have shown they may be effective in counteracting… inflammation, carcinogenesis, and damage from UV radiation”,
“Sulforaphane … inhibition of enzymes involved in carcinogen activation … other mechanisms of Chemoprotection by Sulforaphane”,
“Eradication of Infection: Although many studies with SFN have focused on detoxification of chemical carcinogens, evidence also has been reported for protective effects against viral or bacterial pathogens”,
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Caudill Seed & Warehouse Inc?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Caudill Seed & Warehouse Inc products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Caudill Seed & Warehouse Inc products?
- If you have used products from Caudill Seed & Warehouse Inc and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter